News Releases

Date	Title	Document
Date Jul 28, 2020	Title Oncocyte Announces Rapid Adoption of DetermaRx™ in Community Health Systems	Document PDF
Date Jul 23, 2020	Title Oncocyte to Hold KOL Webinar Showcasing New Data and Real World Usage of DetermaRx™	Document PDF
Date Jul 20, 2020	Title Oncocyte to Report Second Quarter 2020 Financial Results on Wednesday, July 29	Document PDF
Date Jul 20, 2020	Title Oncocyte Announces Final Local Coverage Determination from Noridian Healthcare Solutions for DetermaRx™, Securing National Medicare Payment for the Test Starting August 2020	Document PDF
Date Jul 16, 2020	Title Oncocyte Announces Distribution Agreement with ProGenetics Ltd, Expanding Commercial Availability of DetermaRx™ to Israel	Document PDF
Date Jul 14, 2020	Title Oncocyte Provides an Update on the Rapid Growth of DetermaRx™ Physician Adoption and Testing Volume	Document PDF
Date Jun 29, 2020	Title Oncocyte Announces Completion of DetermaDx™ Clinical Validation Study	Document PDF
Date Jun 15, 2020	Title Oncocyte Transitions to Revenue Generation as Multiple Payers Begin DetermaRx™ Reimbursements	Document PDF
Date May 13, 2020	Title Oncocyte Announces New Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrating That the DetermaIO™ Gene Expression Test May Predict Response to Immunotherapy in Triple Negative Breast Cancer	Document PDF
Date May 12, 2020	Title Oncocyte Provides Corporate Update And Reports First Quarter 2020 Financial Results	Document PDF